2m 2m 2m 2m 2m 2m 2m
STOKE THERAP (STOK)
NASDAQ
$25.71+$0.02 (+0.10%)
Price as of Oct 22, 2026 7:43 PM EDT- $1.7BMarket Cap
- -21.03%1-Year Change
- BiotechnologyIndustry
STOKE THERAP (STOK)
$25.71+$0.02 (+0.10%)
STOK | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $25.68 | ||
Change | -$0.93 (-3.49%) | ||
Open | $26.83 | ||
High | $27.22 | ||
Low | $25.31 | ||
Previous Close | $26.61 | ||
Volume | 2,257,815 | ||
30-Day Average Volume | 1,101,282 | ||
1-Week Change | 10.40% | ||
1-Month Change | -8.45% | ||
1-Year Change | -21.03% | ||
3-Year Change | 588.47% | ||
5-Year Change | 10.55% | ||
Fundamentals | |||
Shares Outstanding | 64.5M | ||
Total Assets | $394.0M | ||
Market Cap | $1.7B | ||
Enterprise Value | $1.5B | ||
Period: QTR TTM FY | |||
Revenue | $9.3M | ||
Net Income | -$61.6M | ||
Free Cash Flow | -$58.6M | ||
EBIT | -$61.6M | ||
EBITDA | -$61.1M | ||
Net Working Capital | $280.6M | ||
EPS | -$0.93 | ||
Enterprise Value/EBITDA | -25 | ||
Enterprise Value/Revenue | 166 | ||
P/B | 5 | ||
P/E | -28 | ||
PEG | 2 | ||
Price/Free Cash Flow | -28 | ||
Price/Operating Cash Flow | -29 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue